We spoke to Dr Dinesh Kalra (Division of Cardiology, Advanced Cardiac Imaging, Rush University Medical Center, Chicago, IL, USA) at C3 2019 about his key interpretations of the findings from the Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation (CABANA) trial, and how this might update approaches to managing atrial fibrillation.
Speaker’s Disclosures: Dinesh Kalra has nothing to declare in relation to this video interview.
Questions:
1. What are your key interpretations of the findings from the Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation (CABANA) trial? (0:04)
2. How do these findings contribute to current understanding and practice, and how should physicians update their approach to managing atrial fibrillation? (0:47)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
